[Federal Register: January 10, 2001 (Volume 66, Number 7)]
[Notices]
[Page 1994-1995]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10ja01-106]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
The 2001 FDA Science Forum--Science Across the Boundaries
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA), Office of Science is
announcing the following meeting entitled ``The 2001 FDA Science
Forum--Science Across the Boundaries.'' The science forum is FDA's key
scientific meeting that seeks to communicate and promote scientific
issues relating to scientific development and associated regulatory
concerns. The 2001 forum is designed to bring FDA scientists together
with representatives from industry, academia, government agencies,
consumers groups, international constituents, and the public to explore
science across the boundaries of these groups.
Date and Time: The science forum will be held on Thursday, February
15, 2001, from 8:30 a.m. to 5 p.m., and Friday, February 16, 2001, from
8:30 a.m. to 4:30 p.m.
Location: Washington Convention Center, 900 Ninth St. NW.,
Washington, DC 20001.
Contact: AOAC International, Fulfillment Department, 301-924-7077,
e-mail: fulfillment@aoac.org, or Donna L. Mentch, Food and Drug
Administration, Office of Science (HF-33), 5600 Fishers Lane,
Rockville, MD 20857, 301-827-3340, e-mail: dmentch@oc.fda.gov.
Registration: Attendees may register from 7 a.m. to 5 p.m. on
February 15, 2001, and from 8 a.m. to 1 p.m. on February 16, 2001.
Registration and program information are also available at http://
www.aoac.org/meetings1/fdascienceforum.html. Attendance will be
limited; therefore, interested parties are encouraged to register
early.
Supplementary Information: Speakers and panelists will address
emerging issues in privacy and confidentiality, modeling and
simulation, leveraging and partnerships across FDA boundaries, and
laboratory accreditation.
[[Page 1995]]
A poster session featuring all areas of FDA regulatory science will
be presented to provide an opportunity for interested scientists to
engage in information exchange with FDA scientists. The session topics
to be discussed include the following:
1. Health Informational Privacy: Individual Right or Public Good;
2. Modeling and Simulation for Transdisciplinary Collaboration: The
Boeing 777 Story;
3. Perspectives on Confidentiality, Conflict of Interest, and
Privacy Issues Surrounding the Advancing Science of Gene Therapy;
4. Modeling and Simulation Across Pharmaceutical Boundaries;
5. Privacy and Confidentiality Issues in Registries and in
Outcomes/Epidemiology Research;
6. Modeling and Simulation in Clinical Product Development for the
New Millennium;
7. Scientific, Privacy, and Ethical Issues Surrounding the
Advancing Science Genetic Predisposition for Breast Cancer;
8. Modeling and Simulation: The Path to the Future;
9. Scientific Training Outside the Boundaries;
10. Next Generation Leveraging;
11. Public Health Preparedness for Bioterrorism: Why Leveraging is
Essential;
12. Partnering Across the Boundaries;
13. Global Partnering: Mutual Recognition Agreements and How They
Affect You.
The science forum is cosponsored by FDA's Office of Science
Coordination and Communication, AOAC International, and FDA's Chapter
of Sigma Xi, The Scientific Research Society.
If you need special accommodations due to a disability, please
contact the AOAC International at least 3 weeks in advance.
Dated: January 4, 2001.
Ann M. Witt,
Acting Associate Commissioner for Policy.
[FR Doc. 01-629 Filed 1-9-01; 8:45 am]
BILLING CODE 4160-01-F